HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination

Christos Thomadakis1, Dimitrios Basoulis2, Olga Tsachouridou3

  • 1Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Viruses
|June 27, 2024
PubMed

Insights

This study tracked Hepatitis C care for people with HIV-HCV co-infection in Greece. Significant gaps and disparities in care persist, especially for migrants and people who inject drugs, impacting treatment outcomes.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Hepatology

Background:

  • People with HIV-HCV co-infection are a key group for Hepatitis C virus (HCV) micro-elimination efforts.
  • Understanding the HCV cascade of care (CoC) is crucial for improving outcomes in this vulnerable population.
  • Greece's HIV-HCV co-infected population presents unique challenges and opportunities for HCV elimination.

Purpose of the Study:

  • To analyze the HCV cascade of care (CoC) among HIV-HCV co-infected individuals in Greece.
  • To identify factors influencing progression through each stage of the HCV care continuum.
  • To assess disparities in HCV care and treatment outcomes across different subgroups.

Main Methods:

  • Analysis of data from 1213 participants in the Athens Multicenter AIDS Cohort Study.
  • Construction of a seven-stage HCV CoC, from diagnosis to sustained virologic response (SVR).
  • Application of logistic and Cox regression models to identify factors associated with CoC progression.

Main Results:

  • Mortality before direct-acting antiviral (DAA) availability was 9.2%, with higher rates among people who inject drugs (PWID).
  • Retention in care and HCV-RNA testing rates were lower for migrants and PWID.
  • While 71% initiated DAAs, very low CD4 counts (<100 cells/μL) were linked to lower initiation odds; SVR rates were high (85.7%) and consistent across groups.

Conclusions:

  • Significant gaps and between-group differences persist in the HCV CoC for HIV-HCV co-infected individuals in Greece as of 2023.
  • Targeted interventions are needed to improve care access and outcomes for marginalized subgroups, including migrants and PWID.
  • Despite challenges, high SVR rates post-DAA treatment indicate the potential for HCV elimination with optimized care pathways.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
934
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
295
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K